Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death. 2021

Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
Department of Molecular, Cell, and Cancer Biology.

Glucocorticoid (GC) resistance remains a clinical challenge in pediatric acute lymphoblastic leukemia where response to GC is a reliable prognostic indicator. To identify GC resistance pathways, we conducted a genome-wide, survival-based, short hairpin RNA screen in murine T-cell acute lymphoblastic leukemia (T-ALL) cells. Genes identified in the screen interfere with cyclic adenosine monophosphate (cAMP) signaling and are underexpressed in GC-resistant or relapsed ALL patients. Silencing of the cAMP-activating Gnas gene interfered with GC-induced gene expression, resulting in dexamethasone resistance in vitro and in vivo. We demonstrate that cAMP signaling synergizes with dexamethasone to enhance cell death in GC-resistant human T-ALL cells. We find the E prostanoid receptor 4 expressed in T-ALL samples and demonstrate that prostaglandin E2 (PGE2) increases intracellular cAMP, potentiates GC-induced gene expression, and sensitizes human T-ALL samples to dexamethasone in vitro and in vivo. These findings identify PGE2 as a target for GC resensitization in relapsed pediatric T-ALL.

UI MeSH Term Description Entries
D008297 Male Males
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D011828 Radiation Chimera An organism whose body contains cell populations of different genotypes as a result of the TRANSPLANTATION of donor cells after sufficient ionizing radiation to destroy the mature recipient's cells which would otherwise reject the donor cells. Chimera, Radiation,Chimeras, Radiation,Radiation Chimeras
D011965 Receptors, Glucocorticoid Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example. Corticoid Type II Receptor,Glucocorticoid Receptors,Glucocorticoids Receptor,Corticoid II Receptor,Corticoid Type II Receptors,Glucocorticoid Receptor,Receptors, Corticoid II,Receptors, Corticoid Type II,Receptors, Glucocorticoids,Corticoid II Receptors,Glucocorticoids Receptors,Receptor, Corticoid II,Receptor, Glucocorticoid,Receptor, Glucocorticoids
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002864 Chromogranins A group of acidic proteins that are major components of SECRETORY GRANULES in the endocrine and neuroendocrine cells. They play important roles in the aggregation, packaging, sorting, and processing of secretory protein prior to secretion. They are cleaved to release biologically active peptides. There are various types of granins, usually classified by their sources. Chromogranin,Granin,Secretogranin,Secretogranins,Granins
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D005576 Colforsin Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant COLEUS FORSKOHLII. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland. Coleonol,Forskolin,N,N-Dimethyl-beta-alanine-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho(2,1-b)pyran-6-yl Ester HCl,NKH 477,NKH-477,NKH477
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
November 1989, Journal of developmental physiology,
Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
March 2021, Scientific reports,
Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
February 1990, Bioscience reports,
Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
June 2016, Biochemical and biophysical research communications,
Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
May 2020, Cells,
Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
April 1996, Cellular immunology,
Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
January 1980, Cellular immunology,
Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
February 1988, Obstetrics and gynecology,
Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
February 1986, The Journal of clinical investigation,
Justine E Roderick, and Kayleigh M Gallagher, and Leonard C Murphy, and Kevin W O'Connor, and Katherine Tang, and Boyao Zhang, and Michael A Brehm, and Dale L Greiner, and Jun Yu, and Lihua Julie Zhu, and Michael R Green, and Michelle A Kelliher
February 2016, Biochimica et biophysica acta,
Copied contents to your clipboard!